Many promising technologies created in academic laboratories struggle to transition to industry because of rapid shifts in research direction, funding constraints and complex challenges, hindering their full development. Here, the founders of ‘INBRAIN Neuroelectronics’, a start-up working on graphene-based high-precision neural interface systems, describe how a different outcome is possible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferrari, A. C. et al. Science and technology roadmap for graphene, related two-dimensional cr ystals, and hybrid systems. Nanoscale 7, 4598 (2015).
Kostarelos, K., Vincent, M., Hebert, C. & Garrido, J. A. Graphene in the design and engineering of next-generation neural interfaces. Adv. Mater. 29, 1700909 (2017).
Hess, L. et al. Graphene transistor arrays for recording action potentials from electrogenic cells. Adv. Mater. 23, 5045 (2011).
Masvidal-Codina, E. et al. High-resolution mapping of infraslow cortical brain activity enabled by graphene microtransistors. Nat. Materials 18, 280 (2019).
Bonaccini Calia, A. et al. Full-bandwidth electrophysiology of seizures and epileptiform activity enabled by flexible graphene microtransistor depth neural probes. Nature Nanotechnology 17, 301 (2022).
Viana, D. et al. Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation. Nat. Nanotechnol. https://doi.org/10.1038/s41565-023-01570-5 (2024).
INBRAIN Neuroelectronics Secures $17 Million in Series a Funding for First AI-Powered Graphene–Brain Interface. Businesswire https://go.nature.com/4aT0tfY (2021).
INBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform. Businesswire https://go.nature.com/47DnKQi (2023).
Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies. Merck https://go.nature.com/3Hf9HWe (2021).
Famm, K., Litt, B., Tracey, K. J., Boyden, E. S. & Slaoui, M. et al. A jump-start for electroceuticals. Nature 496, 159 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The Catalan Institute of Nanoscience and Nanotechnology (ICN2) receives funding support from INBRAIN Neuroelectronics. C.A. is fully employed by INBRAIN Neuroelectronics. All authors have financial interests in INBRAIN Neuroelectronics in the form of shares and/or consultation fees. All authors are co-founders of INBRAIN Neuroelectronics.
Additional information
Related links
INBRAIN Neuroelectronics: https://inbrain-neuroelectronics.com/
Rights and permissions
About this article
Cite this article
Kostarelos, K., Aguilar, C. & Garrido, J.A. Clinical translation of graphene-based medical technology. Nat Rev Electr Eng 1, 75–76 (2024). https://doi.org/10.1038/s44287-024-00020-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44287-024-00020-1